Clinical trial experience with transcatheter aortic valve insertion

Surgical aortic valve replacement has long been considered the standard of care for patients with severe symptomatic aortic stenosis, however, an aging population with increasing complex comorbidities now represents a growing population of patients that is often considered inoperable for a traditional surgical approach. Transcatheter aortic valve implantation is a developing technology that offers an alternative treatment modality for these very high risk patients. This manuscript will review the currently available clinical trial data with transcatheter aortic valve implantation and offer perspective as to the future of this novel technology.

[1]  P. Serruys,et al.  One year follow-up of the multi-centre European PARTNER transcatheter heart valve study , 2010, European heart journal.

[2]  J. Tijssen,et al.  To operate or not on elderly patients with aortic stenosis: the decision and its consequences , 1999, Heart.

[3]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[4]  M. Mack,et al.  United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. , 2008, The Annals of thoracic surgery.

[5]  Philippe Ravaud,et al.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.

[6]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006 .

[7]  F. Mohr,et al.  Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. , 2009, The Annals of thoracic surgery.

[8]  Martyn Thomas,et al.  The global experience with percutaneous aortic valve replacement. , 2010, JACC. Cardiovascular interventions.

[9]  R. Suri.  Malignant Natural History of Asymptomatic Severe Aortic Stenosis: Benefit of Aortic Valve Replacement , 2008 .

[10]  Anson Cheung,et al.  Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience , 2006, Circulation.

[11]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[12]  A. Cribier,et al.  Outcomes and safety of percutaneous aortic valve replacement. , 2009, Journal of the American College of Cardiology.

[13]  A. Colombo,et al.  Safety and Efficacy of the Subclavian Approach for Transcatheter Aortic Valve Implantation With the CoreValve Revalving System , 2010, Circulation. Cardiovascular interventions.

[14]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[15]  T. Dewey,et al.  Transcatheter Aortic Valve Implantation , 2009, Innovations.

[16]  G. Deeb,et al.  Unoperated patients with severe aortic stenosis. , 2007, Journal of the American College of Cardiology.

[17]  P. Kolh,et al.  Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  J. Webb,et al.  A new transcatheter aortic valve and percutaneous valve delivery system. , 2009, Journal of the American College of Cardiology.

[19]  D. Capodanno,et al.  Quality of life assessment after percutaneous aortic valve implantation. , 2009, European heart journal.

[20]  J M Hasenkam,et al.  Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. , 1992, European heart journal.

[21]  Fabian Nietlispach,et al.  Transapical transcatheter aortic valve implantation: follow-up to 3 years. , 2010, The Journal of thoracic and cardiovascular surgery.

[22]  G. Gerosa,et al.  Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. , 2009, JACC. Cardiovascular interventions.

[23]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[24]  G. Schuler,et al.  One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[26]  R. Bansal,et al.  Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. , 2006, The Annals of thoracic surgery.

[27]  Thomas Walther,et al.  Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2010, Circulation.

[28]  Fabian Nietlispach,et al.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.